Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...
A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.